Key Study Highlights: 

Demonstrates how dual-purpose therapeutic targets may address both hepatocellular carcinoma progression and cellular senescence, supporting emerging strategies that link disease treatment with aging biology

Identifies PRPF19 and MAPK9 as targets that suppress tumor cell proliferation while reducing senescence-associated signaling in relevant cellular models

Provides evidence of senomorphic activity, reducing harmful senescence-associated secretory phenotype (SASP) signaling without marked cytotoxicity

Illustrates the effectiveness of integrating AI-driven target discovery, multi-omic human datasets, and experimental validation to prioritize biologically relevant and translationally promising targets

Reinforces Insilico’s broader AI-guided discovery approach for uncovering shared mechanisms across disease and aging

A Carnegie Mellon University-led team has received up to $28.5 million to develop a functional, 3D bioprinted liver for patients with acute liver failure. The temporary, immune-compatible liver is designed to support regeneration of a patient’s own liver, reducing the need for full organ transplants.

Ultraviolet-B (UV-B) semiconductor lasers are highly sought for medical, biotechnology, and precision manufacturing applications; however, previous UV-B laser diodes were limited to pulsed operation or required cryogenic cooling, making continuous room-temperature operation unattainable. Researchers in Japan report the world’s first continuous-wave UV-B semiconductor laser diode operating at room temperature on a low-cost sapphire substrate. This breakthrough advances compact, energy-efficient UV light sources, potentially replacing bulky gas-based lasers in healthcare, industrial, and scientific research applications worldwide.